Developing a Brief Intervention to Communicate Cardiovascular Risk to Patients Presenting to the Emergency Department With Chest Pain: a Co-Production Approach. Phase 2.
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Co-designed cardiovascular brief intervention.
- Who it may be relevant to
- Registry conditions: Cardiovascular Diseases. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United Kingdom
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Some patients who come to the emergency department with chest pain and have not had a heart attack, are at an increased risk of having a heart attack in the future. The investigators know this by taking a blood test (troponin) which looks at damage to the patient's heart. These patients are often sent home from hospital with no information about their risk of heart disease. A patient survey revealed that patients in the emergency department would like to receive more information about heart disease. In this study the investigators will provide patients who are at increased risk of cardiovascular disease with their troponin value. The investigators will deliver this information within a cardiovascular brief intervention, which is a short conversation with a patient about their health. In a previous study the investigators carried out some interviews with patients to find out how their results should be delivered and what information should be included in a cardiovascular brief intervention. The investigators also asked them the best way to provide patients with this information. The aim of this part of the study it to determine if the new cardiovascular brief intervention helps patients understand their risk and if it results in them making changes to their health.
Interventions
- Behavioral Co-designed cardiovascular brief intervention
Patients will be randomised to a brief intervention where they will be informed of their high-sensitivity cardiac troponin value and cardiovascular risk.
Primary outcome measures
- Cardiovascular Health [Time frame: 90 days]
Secondary outcome measures (3)
- High sensitivity cardiac troponin concentrations [Time frame: 90 days]
- Motivational readiness to make changes to improve their cardiovascular health [Time frame: 90 days]
- The difference in scores within each component of the Life's Essential 8 cardiovascular health score [Time frame: 90 days]
Eligibility criteria
Inclusion criteria
- Patients who present to the Emergency Department with symptoms suggestive of acute coronary syndrome
- A maximum high-sensitivity cardiac troponin I between 5 ng/L and the sex-specific 99th centile.
- Resides in Scotland and has a CHI number
- Adults aged 18 and over
- No history of cardiovascular disease
- At least 1 modifiable cardiovascular risk factor: current smoker, hypertension (140/90 mmHg), hypercholesterolaemia (>6.0 mmol/L), overweight and obesity (BMI >25), hyperglycaemia or diabetes mellitus.
- Patients who are able to provide informed consent
Exclusion criteria
- Patients with a diagnosis of acute coronary syndrome during index presentation
- Patients who are not able to give informed consent
- Patients who do not speak English
- Patients who are unable to attend hospital as outpatient to receive the cardiovascular brief intervention
- Patients with ongoing or planned cardiovascular investigations or interventions
- Patients with chronic kidney disease and a eGFR below 30 ml/min
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Prevention
Study locations
United Kingdom · 1 center
- NHS Lothian — Edinburgh
Identifiers
NCT: NCT06903442 · AC25029